DID DAVID J. LLEWELLYN CAUSE YOU INVESTMENT LOSSES?
David Llewellyn Of Cambridge Investment Research, Inc. Has A Customer Complaint For Alleged Broker Misconduct
Who is David Llewellyn of Cambridge Investment Research, Inc.?
David Llewellyn (CRD #5288989) who is currently registered with Cambridge Investment Research, Inc. and located in Deland, Florida is a subject of one of our many securities industry sales practice abuse investigations.
David Llewellyn Customer Complaint
David Llewellyn has been the subject of at least one customer complaint that we know about, which was filed in the last year to recover investment losses. The allegations made in the FINRA reported customer complaint for investment losses were misrepresentations and unsuitable recommendations related to variable annuity investment. David Llewellyn’s customer complaint was settled in favor of the investor.
David Llewellyn Red Flags & Your Rights As An Investor
Of course, David Llewellyn did not admit to any of the allegations. But regardless of whether an arbitration award was entered, a settlement occurred, or the customer complaint is still pending, the allegations made by customers are red flags which should put all current and former customers of David Llewellyn at Cambridge Investment Research, Inc. on alert to review carefully the activity and performance of their accounts and question whether David Llewellyn has engaged in any stockbroker misconduct that may have caused them investment losses. The large number of customer complaints at Cambridge Investment Research, Inc. also raises questions about the brokerage firm’s supervisory practices. If these red flags raise questions, call us and we will inform you of your rights as an investor.
File A Claim To Recover Your Investment Losses At Cambridge Investment Research, Inc. Due To David Llewellyn
If you have questions about Cambridge Investment Research, Inc. and/or David Llewellyn and the management or performance of your accounts, please contact Attorney Pearce for a free initial consultation via email or Toll Free at 1-800-732-2889.